The microbiology of airway infection in CF has been an area of intense investigation for the past several decades. This session will review the key milestones in CF microbiology during this time, highlight current areas of investigation and discuss emerging concepts and technologies that hold promise to further advance our understanding of the role of infection in the pathology of lung disease in CF. At the completion of this session, participants will have a more complete understanding of what airway microbiology has taught us about CF lung disease progression, how this impacts current treatment strategies and how new technologies have potential to alter current therapy.
Describe the major milestones that have advanced our understanding of CF microbiology.
Discuss current areas of intense investigation regarding CF microbiology.
Explain how new concepts and technologies will advance our understanding of CF microbiology.